Mylan 'Declared War' On AstraZeneca IP, Fed. Circ. Hears

By Michael Macagnone
January 4, 2016, 7:58 PM EST

AstraZeneca urged a Federal Circuit panel to preserve a Delaware patent infringement suit against Mylan Monday, maintaining Mylan "declared war" on AstraZeneca's exclusivity rights nationwide by developing generic versions of its...

Already a subscriber? Click here to view full article